Recent Searches

Share this Post

Share on facebook
Share on twitter
Share on linkedin
Share on email

Home
Neurobiology solutions
Overview of Friedreich’s Ataxia Models - Cat Lutz, Ph.D.

Overview of Friedreich’s Ataxia Models - Cat Lutz, Ph.D.

Published Date October 23, 2020

Loading, please wait

Error - something went wrong!

Ready to discuss your project needs with our experts?

Thank you, we will be in touch soon!

Previous Video

Mouse Models of Rett Syndrome

The establishment of a new platform to assess preclinical allele dependent phenotypes
Next Video

MiceTech Talk Episode 22: Let’s Talk Exploring Neurobiology Solutions (Oct. 27, 2020)

October 27, 2020 - In this episode, we share with you highlights of JAX preclinical research studies using mouse models for ALS, Rett Syndrome, Friedreich's Ataxia, and more!

Other content in this Stream

6 months ago
Preclinical Neurobiology Services Booklet

Read Flipbook
over 1 year ago
Preclinical Assessment of Investigational Gene Therapy Products for Neuroscience

Learn how to overcome the challenges to develop gene therapies, specifically for neurodevelopmental and neurodegenerative diseases.

Watch Video
almost 3 years ago
C9Orf72 Tech Spec Sheet

The Jackson Laboratory is the exclusive service provider for robust, reliable, reproducible gene therapy, efficacy, and safety studies in the C9orf72 mouse model, the most common form of familial ALS.

Read Flipbook
over 1 year ago
JAX Tech Talk Episode 59: Let’s Talk iPSCs and Their Value in Tackling Neurodegenerative Diseases (Sep. 20, 2022)

Dr. Mark Cookson talks about the unique aspects of the collection of human isogenic iPSC lines and how it can benefit the wider scientific community in their shared quest to understand and fight ADRD.

Watch Video
over 1 year ago
In Vivo Drug Discovery Platforms for Amyotrophic Lateral Sclerosis

Watch this webinar to review phenotypic characteristics, considerations for selecting therapeutically relevant ALS models, and more!

Watch Video
over 2 years ago
Important Considerations for Generating Genetic Humanized Mouse Models

The term humanization is used, to much confusion, to mean several different things in mouse research. While broad in scope and technique, all humanized mouse models share a common goal – to better lev

Learn More
over 2 years ago
JAX Tech Talk Episode 41: Let’s Talk Cre-Lox for Neuroscientists (Aug. 10, 2021)

Aug. 10, 2021 - In this episode, we will explore the use of Cre-lox technology to control gene expression in neuronal cell types, and more.

Watch Video
over 3 years ago
MODEL-AD: Creating new mouse models for late-onset Alzheimer’s disease

Watch Video
over 3 years ago
Early Electrophysiology & Biochemical Biomarkers in Mouse Models for Amyotrophic Lateral Sclerosis.

Watch Video
over 3 years ago
Mouse Models of Rett Syndrome

The establishment of a new platform to assess preclinical allele dependent phenotypes

Watch Video
over 3 years ago
MiceTech Talk Episode 22: Let’s Talk Exploring Neurobiology Solutions (Oct. 27, 2020)

October 27, 2020 - In this episode, we share with you highlights of JAX preclinical research studies using mouse models for ALS, Rett Syndrome, Friedreich's Ataxia, and more!

Watch Video
over 3 years ago
A View on ALS Drug Discovery - Learnings From the Front Lines of Translational Disease Modeling

Join Cat Lutz, Ph.D., Senior Director In Vivo Pharmacology & Mouse Repository at JAX as she'll discuss neurodegenerative diseases, rare diseases, and her group’s latest work in preclinical studies usi

Watch Video
almost 4 years ago
MiceTech Talk Episode 12: Let's Talk Latest Advances in Alzheimer's Disease Research (Aug. 4, 2020)

August 4, 2020 - We highlight some of the latest studies and discoveries presented at the AAIC Conference, the most influential international meeting dedicated to advancing dementia science.

Watch Video
almost 4 years ago
Moving beyond amyloid to treat Alzheimer's disease

Beta-amyloid peptid. The amyloid precursor protein being cleaved by gamma and beta secretases and releasing the amyloid beta peptide, which can accumulate to amyloid plaques, one of the main...

Learn More
about 4 years ago
Model Organism Development and Evaluation for Late-Onset Alzheimer's Disease

Read Flipbook
about 4 years ago
FcRn: Preclinical Therapeutic Antibody and Albumin-Conjugate Evaluation

Read Flipbook
4 months ago
Aged C57BL/6J Mice for Research Studies

Read Flipbook
almost 5 years ago
The Versatile Mouse Model for Rare Disease Research

More than 7,000 rare (or orphan) diseases have been described so far and affect over 350 million people worldwide. Unfortunately, less than 10% of these diseases have an approved treatment, and...

Learn More
about 5 years ago
Revealing antibody half-life and stability using FcRn mouse models from JAX

The approval of Orthoclone OKT3® (muromonab-CD3) in 1986 marked the first appearance of monoclonal antibodies in the clinic. In the over 20 years since, more than 70 antibodies have been approved...

Learn More
over 5 years ago
Investigating Stroke Therapeutic Targets Using JAX Aged C57BL/6J Mice

Introduction The brain is a highly complex organ comprised of a large number of cells and molecules, each with its own unique function. Diseases that affect the central nervous system (CNS), such...

Learn More

Recommended for you

Return to Home